Literature DB >> 15115909

Galectin-4 in normal tissues and cancer.

Margaret E Huflejt1, Hakon Leffler.   

Abstract

Galectin-4 belongs to a subfamily of galectins composed of two carbohydrate recognition domains within the same peptide chain. The two domains have all the conserved galectin signature amino acids, but their overall sequences are only approximately 40% identical. Both domains bind lactose with a similar affinity as other galectins, but their respective preferences for other disaccharides, and larger saccharides, are distinctly different. Thus galectin-4 has a property of a natural cross-linker, but in a modified sense since each domain prefers a different subset of ligands. Similarly to other galectins, galectin-4 is synthesized as a cytosolic protein, but can be externalized. During development and in adult normal tissues, galectin-4 is expressed only in the alimentary tract, from the tongue to the large intestine. It is often found in relatively insoluble complexes, as a component of either adherens junctions or lipid rafts in the microvillus membrane, and it has been proposed to stabilize these structures. Strong expression of galectin-4 can be induced, however, in cancers from other tissues including breast and liver. Within a collection of human epithelial cancer cell lines, galectin-4 is overexpressed and soluble in those forming highly differentiated polarized monolayers, but absent in less differentiated ones. In cultured cells, intracellular galectin-4 may promote resistance to nutrient starvation, whereas--as an extracellular protein--it can mediate cell adhesion. Because of its distinct induction in breast and other cancers, it may be a valuable diagnostic marker and target for the development of inhibitory carbohydrate-based drugs. Copyright 2004 Kluwer Academic Publishers

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115909     DOI: 10.1023/B:GLYC.0000025819.54723.a0

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  59 in total

1.  Differences in C/EBPs in normal tissue and papillomas of the larynx.

Authors:  L Jin; G Y Yang; K Auborn
Journal:  Cell Prolif       Date:  1998 Jun-Aug       Impact factor: 6.831

2.  Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.

Authors:  Nathalie Nagy; Hugues Legendre; Olivier Engels; Sabine André; Herbert Kaltner; Kojiro Wasano; Yehiel Zick; Jean-Claude Pector; Christine Decaestecker; Hans-Joachim Gabius; Isabelle Salmon; Robert Kiss
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

3.  Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.

Authors:  H Lahm; S André; A Hoeflich; J R Fischer; B Sordat; H Kaltner; E Wolf; H J Gabius
Journal:  J Cancer Res Clin Oncol       Date:  2001       Impact factor: 4.553

4.  Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells. Galectin-4 is localized at sites of cell adhesion.

Authors:  M E Huflejt; E T Jordan; M A Gitt; S H Barondes; H Leffler
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

Authors:  Y Hippo; M Yashiro; M Ishii; H Taniguchi; S Tsutsumi; K Hirakawa; T Kodama; H Aburatani
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma.

Authors:  U Wollina; T Graefe; S Feldrappe; S André; K Wasano; H Kaltner; Y Zick; H-J Gabius
Journal:  J Cancer Res Clin Oncol       Date:  2001-11-16       Impact factor: 4.553

7.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

8.  Galectin-4 and small intestinal brush border enzymes form clusters.

Authors:  E M Danielsen; B van Deurs
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

9.  Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.

Authors:  Pernilla Sörme; Barbro Kahl-Knutsson; Margaret Huflejt; Ulf J Nilsson; Hakon Leffler
Journal:  Anal Biochem       Date:  2004-11-01       Impact factor: 3.365

Review 10.  Galectin-3 and metastasis.

Authors:  Yukinori Takenaka; Tomoharu Fukumori; Avraham Raz
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

View more
  52 in total

Review 1.  Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.

Authors:  Alexander V Timoshenko
Journal:  Cell Mol Life Sci       Date:  2015-08-06       Impact factor: 9.261

2.  The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells.

Authors:  Victor L Thijssen; Sarah Hulsmans; Arjan W Griffioen
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

Review 3.  Roles of galectins in inflammatory bowel disease.

Authors:  Akira Hokama; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

4.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the N-terminal carbohydrate-recognition domain of human galectin-4.

Authors:  Ana Lucia L R Zimbardi; Matheus P Pinheiro; Marcelo Dias-Baruffi; M Cristina Nonato
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-29

Review 5.  Role of galectins in re-epithelialization of wounds.

Authors:  Noorjahan Panjwani
Journal:  Ann Transl Med       Date:  2014-09

6.  Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.

Authors:  Viola A Heinzelmann-Schwarz; Richard A Scolyer; James P Scurry; Alison N Smith; Margaret Gardiner-Garden; Andrew V Biankin; Sally Baron-Hay; Carolyn Scott; Robyn L Ward; Daniel Fink; Neville F Hacker; Robert L Sutherland; Philippa M O'Brien
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

7.  Gene expression profiling in sinonasal adenocarcinoma.

Authors:  Dominique Tripodi; Sylvia Quéméner; Karine Renaudin; Christophe Ferron; Olivier Malard; Isabelle Guisle-Marsollier; Véronique Sébille-Rivain; Christian Verger; Christian Géraut; Catherine Gratas-Rabbia-Ré
Journal:  BMC Med Genomics       Date:  2009-11-10       Impact factor: 3.063

8.  Innate immune lectins kill bacteria expressing blood group antigen.

Authors:  Sean R Stowell; Connie M Arthur; Marcelo Dias-Baruffi; Lilian C Rodrigues; Jean-Philippe Gourdine; Jamie Heimburg-Molinaro; Tongzhong Ju; Ross J Molinaro; Carlos Rivera-Marrero; Baoyun Xia; David F Smith; Richard D Cummings
Journal:  Nat Med       Date:  2010-02-14       Impact factor: 53.440

9.  Galectins are human milk glycan receptors.

Authors:  Alexander J Noll; Jean-Philippe Gourdine; Ying Yu; Yi Lasanajak; David F Smith; Richard D Cummings
Journal:  Glycobiology       Date:  2016-01-07       Impact factor: 4.313

10.  Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer.

Authors:  Seung Won Kim; Ki Cheong Park; Soung Min Jeon; Tak Bum Ohn; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Cell Oncol (Dordr)       Date:  2013-02-02       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.